about
Adult bone marrow: which stem cells for cellular therapy protocols in neurodegenerative disorders?Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord InjuryDeveloping stem cell therapies for juvenile and adult-onset Huntington's diseaseThe Regenerative Role of the Fetal and Adult Stem Cell SecretomePlacental mesenchymal stromal cells rescue ambulation in ovine myelomeningocele.Neuroprotective Potential of Mesenchymal Stem Cell-Based Therapy in Acute Stages of TNBS-Induced Colitis in Guinea-PigsRecent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral SclerosisA concerted HIF-1α/MT1-MMP signalling axis regulates the expression of the 3BP2 adaptor protein in hypoxic mesenchymal stromal cellsThe stem cell secretome and its role in brain repair.How stem cells speak with host immune cells in inflammatory brain diseasesBone Marrow Mesenchymal Stem-Cell Transplantation Promotes Functional Improvement Associated with CNTF-STAT3 Activation after Hemi-Sectioned Spinal Cord Injury in Tree Shrews.What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury?Stem cell therapy for cerebral ischemia: from basic science to clinical applications.In vitro evaluation of cell-seeded chitosan films for peripheral nerve tissue engineering.Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications.Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions.Mesenchymal stem cell conditioning promotes rat oligodendroglial cell maturation.Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis (ALS)--in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia.Stem cells in regenerative medicine.Electrophysiological functional recovery in a rat model of spinal cord hemisection injury following bone marrow-derived mesenchymal stem cell transplantation under hypothermiaTargeting the body to protect the brain: inducing neuroprotection with remotely-applied near infrared light.The primary cilium as a biomarker in the hypoxic adaptation of bone marrow-derived mesenchymal stromal cells: a role for the secreted frizzled-related proteinsHarnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis.Mesenchymal stromal cell therapy attenuated lung and kidney injury but not brain damage in experimental cerebral malaria.Duchenne muscular dystrophy: current cell therapiesMesenchymal stem/stromal cells-a key mediator for regeneration after perinatal morbidity?Fusion of Human Fetal Mesenchymal Stem Cells with "Degenerating" Cerebellar Neurons in Spinocerebellar Ataxia Type 1 Model Mice.The potential of transcranial photobiomodulation therapy for treatment of major depressive disorder.High-throughput screening of stem cell therapy for globoid cell leukodystrophy using automated neurophenotyping of twitcher mice.Chromatographically isolated CD63+CD81+ extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBIHistopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model.Systemic administration of human adipose-derived stem cells reverts nociceptive hypersensitivity in an experimental model of neuropathy.Reciprocal interactions of mouse bone marrow-derived mesenchymal stem cells and BV2 microglia after lipopolysaccharide stimulation.Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantationTransplantation of Mesenchymal Stem Cells for Acute Spinal Cord Injury in Rats: Comparative Study between Intralesional Injection and Scaffold Based Transplantation.Multipotent stromal cells alleviate inflammation, neuropathology, and symptoms associated with globoid cell leukodystrophy in the twitcher mouse.Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model.Metabolic determinants of the immune modulatory function of neural stem cellsTransplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis.Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome.
P2860
Q21285020-B761B3E9-3D5A-42FE-96A4-4331774B6B28Q26748907-B653B18E-6D52-4A24-9DD8-2C37F1575D3BQ26799722-3EC3D871-9157-44D4-A3E0-1829E981AB79Q27004398-97DAC653-F638-4500-856B-578ECDB5F82BQ27301172-F38C9CB3-609D-41F1-8812-F66040805F09Q27316366-6921BBAB-92FE-4A55-B4B0-8792D1723E95Q27338320-6A315493-E259-429D-A838-C0CF10F275D1Q30010277-45D3BF31-DE74-4EB6-8843-EED3C78988F6Q33771698-56A563B9-32E6-4E12-B51B-8C48DEDB59C1Q33776557-915D37FF-76D2-419D-A6FE-55AE3A35A90BQ33843043-3AD3183D-7985-448A-92D5-D8A751DB39A5Q34029285-76FDFADB-B704-49A0-BFDF-495F5606E71CQ34129832-3014AD9D-73C4-4B89-B5C2-85167DFEEF07Q34164208-00E72963-157D-4ACF-891D-C40A4860B56DQ34290984-E123E7BF-D2E9-4270-A819-CA9B2C045324Q34321448-5B72A2A2-8FFD-4895-ABF6-4932A533E085Q34950646-7D52A27E-4DA1-4D78-9AD4-757E8D2209A8Q34998538-382E8256-5A0D-452B-9E7F-274E33AEA3E0Q35025126-E0E855B2-AAAD-4900-9DEC-62660FB8A193Q35134944-06735377-9D25-4849-942C-6BB6940CD1F4Q35403211-B8F19CCC-47B9-491A-A544-20B8268100FAQ35440270-6EE63E36-B615-4AC7-B9C1-DC248823C92AQ35603241-B3A26C50-0DCF-44B1-8D73-D6D6A3E9686CQ35711050-AB1350D0-B914-43A6-823D-721CC5CC8BDBQ35780806-6F0D6156-713F-4041-A000-0FD6D46B6050Q35921652-02C5BF0C-456D-48A0-9CD8-1A084241D700Q36179233-35E95FD9-D01C-41CD-AF36-C1CA9539811BQ36288255-6F28AA03-0400-4325-8A29-F56224380D0AQ36350625-7A58CE36-D961-47DA-B983-0D5CE2CDC39FQ36459432-A7CE4E46-27DB-46A4-9B24-0F8FAF6240F4Q36615851-381C6526-9667-490A-888D-0D1D60655C71Q36733628-BEEFE65E-0E99-405B-B2E1-4D7C773FA65FQ36998367-79DC5FA3-8AA0-4C67-ABBC-F499EA6FCF7AQ37125914-D5F27C6B-7F16-4493-A5E0-57A4EB6CD6EFQ37153172-C39E058A-1535-41B9-B17C-7FF29C3ACE66Q37164768-F5690FE4-4EA0-4D51-AE53-55C81652844BQ37202733-5A73FB8F-66BF-4B28-9DD5-5E2C271D44F6Q37228719-0A76899D-7E81-4433-AF1F-4AB744B5B40EQ37521318-6BFD1C7D-72EB-4916-8C5D-27E16BA90E61Q37556986-3959B05A-6716-46E7-8775-536D9990B05F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuroprotective features of mesenchymal stem cells.
@en
Neuroprotective features of mesenchymal stem cells.
@nl
type
label
Neuroprotective features of mesenchymal stem cells.
@en
Neuroprotective features of mesenchymal stem cells.
@nl
prefLabel
Neuroprotective features of mesenchymal stem cells.
@en
Neuroprotective features of mesenchymal stem cells.
@nl
P50
P1476
Neuroprotective features of mesenchymal stem cells
@en
P2093
Federica Benvenuto
P356
10.1016/J.BEHA.2011.01.004
P577
2011-02-25T00:00:00Z